CEFUROXIME AXETIL Drug Patent Profile
✉ Email this page to a colleague
When do Cefuroxime Axetil patents expire, and when can generic versions of Cefuroxime Axetil launch?
Cefuroxime Axetil is a drug marketed by Sun Pharm Inds Ltd, Alkem Labs Ltd, Anda Repository, Ani Pharms, Apotex, Aurobindo Pharma, Chartwell Rx, Fosun Pharma, Lupin, and Ranbaxy Labs Ltd. and is included in eleven NDAs.
The generic ingredient in CEFUROXIME AXETIL is cefuroxime axetil. There are sixty-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefuroxime Axetil
A generic version of CEFUROXIME AXETIL was approved as cefuroxime axetil by APOTEX on October 2nd, 2002.
Summary for CEFUROXIME AXETIL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,017 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CEFUROXIME AXETIL |
| DailyMed Link: | CEFUROXIME AXETIL at DailyMed |
See drug prices for CEFUROXIME AXETIL
Recent Clinical Trials for CEFUROXIME AXETIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Louisville | Early Phase 1 |
| James Graham Brown Cancer Center | Early Phase 1 |
| Julio Ramirez | Early Phase 1 |
Pharmacology for CEFUROXIME AXETIL
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFUROXIME AXETIL
US Patents and Regulatory Information for CEFUROXIME AXETIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CEFUROXIME AXETIL | cefuroxime axetil | FOR SUSPENSION;ORAL | 065323-001 | Feb 5, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Fosun Pharma | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065126-001 | Oct 28, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ranbaxy Labs Ltd | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065043-001 | Feb 15, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Anda Repository | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065359-003 | Feb 15, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alkem Labs Ltd | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065496-002 | Jun 7, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Aurobindo Pharma | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065308-001 | Mar 29, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
